| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 54 | 116 | 103 | 116 | 126 | 116 | 114 | 119 | 107 | 124 | 117 | 126 | 127 | 146 | 138 | 159 | 160 | 188 | 174 | 179 | 195 | 208 | 210 | 222 | 240 |
| Expenses | 38 | 62 | 54 | 58 | 66 | 62 | 63 | 68 | 65 | 72 | 69 | 72 | 73 | 82 | 82 | 92 | 95 | 107 | 102 | 105 | 115 | 120 | 119 | 124 | 132 |
| EBITDA | 16 | 54 | 49 | 59 | 60 | 54 | 51 | 51 | 43 | 52 | 48 | 54 | 54 | 64 | 55 | 66 | 65 | 81 | 72 | 73 | 81 | 88 | 91 | 98 | 107 |
| Operating Profit % | 27 % | 45 % | 46 % | 49 % | 46 % | 45 % | 43 % | 41 % | 38 % | 40 % | 39 % | 41 % | 40 % | 41 % | 38 % | 41 % | 39 % | 42 % | 40 % | 39 % | 39 % | 41 % | 42 % | 44 % | 43 % |
| Depreciation | 12 | 14 | 13 | 13 | 12 | 13 | 13 | 15 | 14 | 16 | 20 | 11 | 13 | 14 | 15 | 16 | 17 | 17 | 18 | 19 | 21 | 22 | 24 | 24 | 25 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 9 | 11 |
| Profit Before Tax | 1 | 36 | 33 | 43 | 44 | 38 | 34 | 31 | 24 | 31 | 22 | 37 | 36 | 45 | 35 | 44 | 42 | 57 | 47 | 47 | 52 | 58 | 58 | 64 | 71 |
| Tax | -1 | 9 | 8 | 11 | 11 | 10 | 8 | 8 | 6 | 8 | 6 | 9 | 9 | 11 | 9 | 10 | 10 | 15 | 11 | 13 | 14 | 15 | 15 | 16 | 18 |
| Net Profit | 2 | 27 | 25 | 32 | 33 | 28 | 26 | 24 | 18 | 24 | 17 | 28 | 26 | 34 | 26 | 34 | 32 | 42 | 35 | 35 | 39 | 43 | 43 | 48 | 53 |
| EPS in ₹ | 3.55 | 2.59 | 2.43 | 3.08 | 3.23 | 2.72 | 2.48 | 2.33 | 1.71 | 2.29 | 1.60 | 2.69 | 2.57 | 3.26 | 2.53 | 3.27 | 3.06 | 4.10 | 3.42 | 3.38 | 3.76 | 4.21 | 4.20 | 4.66 | 5.16 |
Vijaya Diagnostic Centre
Vijaya Diagnostic Centre
1,486.50
-24.10
(-1.60%)
Market Cap
15,295.60 Cr
PE Ratio
83.04
Volume
2,74,726.00
Day High - Low
1,573.00 - 1,472.20
52W High-Low
1,525.00 - 848.00
Key Fundamentals
Market Cap
15,295.60 Cr
EPS
16.81
PE Ratio
83.04
PB Ratio
16.26
Book Value
92.93
EBITDA
336.93
Dividend Yield
0.13 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
17.99
Debt to Equity
0.40
Analyst Rating and Forecast
- By Refinitiv from8 analysts
Actual
Company News
View All News
Vijaya Diagnostic Centre Limited has certified the distribution of ₹51.84 lakh from the sale of fractional shares arising from its amalgamation with Medinova Diagnostic Services.
Vijaya Diagnostic Centre Limited reports Q1FY27 results with revenue of ₹2,037 Mn and EBITDA of ₹850 Mn. The company expanded its network to 166 centres and launched AI diagnostics.
Vijaya Diagnostic Centre Ltd reported a 36% YoY rise in consolidated net profit to ₹531.01 lakh for Q1FY26, driven by an 22.8% surge in revenue. The Board also recommended a 200% dividend.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,968.40 | #1 32,997.82 | 59.90 | #1 2,864.20 | 12.11 | #1 510 | 27.24 | 76.64 | |
1,486.50 | #2 15,295.60 | #9 83.04 | #6 814.20 | #7 16.36 | #3 182 | #4 37.56 | 66.26 | |
558.50 | 11,579.26 | 56.47 | 1,671.40 | 24.15 | 191 | 25.61 | 46.37 | |
606.00 | 9,645.42 | 58.33 | 846.00 | 20.48 | 163 | 33.94 | 56.85 | |
675.90 | 6,782.03 | 80.31 | 1,023.40 | 32.93 | 77 | 35.02 | 48.47 | |
556.75 | 1,806.02 | 18.37 | 772.77 | 4.05 | 106 | #1 101.45 | 52.32 | |
304.45 | 1,585.60 | 44.85 | 310.41 | 21.30 | 34 | 40.22 | 76.28 | |
595.55 | 1,163.93 | #1 17.63 | 498.18 | #1 237.06 | 69 | 65.45 | 51.04 | |
1,225.50 | 1,051.81 | 17.85 | 141.92 | 27.17 | 61 | 22.50 | 48.45 | |
294.70 | 937.46 | -35.57 | 1,319.27 | 12.68 | -3 | -92.48 | 36.82 |
Growth Rate
Revenue Growth
16.36 %
Net Income Growth
26.56 %
Cash Flow Change
22.46 %
ROE
-0.77 %
ROCE
-1.44 %
EBITDA Margin (Avg.)
-3.17 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 234 | 301 | 482 | 541 | 714 | 853 | 983 | 1,274 | 1,507 |
| Fixed Assets | 119 | 151 | 272 | 268 | 371 | 524 | 742 | 865 | 985 |
| Current Assets | 103 | 138 | 186 | 239 | 270 | 276 | 211 | 307 | 322 |
| Capital Work in Progress | 3 | 3 | 10 | 9 | 34 | 28 | 9 | 70 | 34 |
| Investments | 73 | 69 | 55 | 28 | 54 | 139 | 109 | 185 | 5 |
| Other Assets | 39 | 78 | 146 | 236 | 255 | 163 | 123 | 154 | 0 |
| Total Equity & Liabilities | 234 | 301 | 482 | 541 | 714 | 853 | 983 | 1,274 | 1,507 |
| Current Liabilities | 40 | 50 | 59 | 44 | 66 | 66 | 73 | 163 | 124 |
| Non Current Liabilities | 33 | 40 | 150 | 138 | 178 | 241 | 250 | 312 | 426 |
| Total Equity | 161 | 211 | 274 | 359 | 470 | 547 | 660 | 799 | 957 |
| Reserve & Surplus | 155 | 204 | 270 | 355 | 458 | 535 | 647 | 786 | 947 |
| Share Capital | 5 | 5 | 5 | 5 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -44 | -7 | 46 | -49 | 4 | 13 | -2 | -9 |
| Investing Activities | -98 | -90 | -31 | -130 | -123 | -110 | -141 | -182 |
| Operating Activities | 62 | 91 | 106 | 130 | 158 | 165 | 183 | 225 |
| Financing Activities | -8 | -7 | -30 | -49 | -31 | -42 | -45 | -52 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 60.00 % | 54.78 % | 54.78 % | 54.78 % | 55.04 % | 55.01 % | 55.01 % | 55.01 % | 54.98 % | 54.90 % | 54.87 % | 54.06 % | 53.93 % | 53.91 % | 53.91 % | 53.05 % | 52.63 % | 52.60 % | 52.60 % | 52.51 % | 52.51 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 20.09 % | 20.08 % | 18.14 % | 17.54 % | 19.36 % | 19.56 % | 18.27 % | 15.10 % | 13.38 % | 11.66 % |
| DIIs | 0.00 % | 14.09 % | 13.30 % | 12.88 % | 12.76 % | 15.28 % | 14.23 % | 13.90 % | 19.03 % | 17.99 % | 19.55 % | 20.80 % | 21.49 % | 23.46 % | 24.63 % | 23.72 % | 24.07 % | 25.34 % | 28.59 % | 29.93 % | 31.61 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.45 % | 3.71 % | 3.82 % | 4.00 % | 4.97 % | 5.18 % | 5.13 % | 5.03 % | 5.06 % | 4.63 % | 4.38 % | 3.98 % | 3.94 % | 3.43 % | 3.42 % | 3.24 % | 3.20 % | 3.14 % | 3.47 % | 3.49 % |
| Others | 40.00 % | 25.68 % | 28.21 % | 28.52 % | 28.20 % | 24.74 % | 25.58 % | 25.96 % | 20.96 % | 22.05 % | 20.95 % | 0.67 % | 0.52 % | 0.55 % | 0.49 % | 0.45 % | 0.50 % | 0.59 % | 0.57 % | 0.71 % | 0.74 % |
| No of Share Holders | 7 | 2,34,724 | 82,139 | 79,021 | 77,229 | 76,985 | 79,059 | 76,532 | 73,850 | 72,795 | 66,204 | 66,724 | 62,415 | 62,258 | 60,952 | 66,891 | 62,115 | 58,994 | 57,784 | 62,946 | 67,251 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 | 2 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.16 | 0.1 | 0.23 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Sept 2022 |  Dividend | ₹ 1.00 /share | 20 Sept 2022 | 389.20 | 402.80 |
| 13 Sept 2023 | Dividend | ₹ 1.00 /share | 13 Sept 2023 | 376.05 | 473.60 |
| 30 Aug 2024 | Dividend | ₹ 1.00 /share | 30 Aug 2024 | 666.05 | 892.05 |
| 06 Sept 2024 |  Annual General Meeting | NA | 06 Sept 2024 | 819.80 | 947.20 |
| 07 Nov 2024 |  Quarterly Result Announcement | NA | 07 Nov 2024 | 934.40 | 980.25 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 1,160.00 | 1,078.50 |
| 25 Apr 2025 |  Extraordinary General Meeting | NA | 25 Apr 2025 | 1,050.75 | 1,061.80 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 1,018.20 | 993.10 |
| 28 Jul 2025 | Quarterly Result Announcement | NA | 28 Jul 2025 | 1,045.40 | 1,070.30 |
| 29 Aug 2025 | Dividend | ₹ 2.00 /share | 29 Aug 2025 | 993.10 | 993.45 |
| 05 Sept 2025 | Annual General Meeting | NA | 05 Sept 2025 | 1,050.00 | 1,089.40 |
| 04 Nov 2025 | Quarterly Result Announcement | NA | 04 Nov 2025 | 989.40 | 1,019.70 |
| 25 Nov 2025 |  Merger - Demerger | 22:1 | 25 Nov 2025 | 1,029.00 | 1,029.00 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 970.40 | 994.55 |
| 07 May 2026 | Quarterly Result Announcement | NA | 07 May 2026 | 1,112.80 | 1,189.30 |
| 06 Aug 2026 | Quarterly Result Announcement | NA | 06 Aug 2026 | 1,348.95 | 1,389.60 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome6 days ago
6 days agoAudit Committee And Independent Director Report Certifying The Distribution Of Proceeds To Shareholders Of Medinova Diagnostic Services Limited For Fractional Entitlements Under Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 Dated June 20 20236 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation7 days ago
7 days agoUn-Audited Financial Results For The Quarter Ended June 30 20267 days ago
7 days agoBoard Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter Ended June 30 20267 days ago
7 days agoDisclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 29, 2026
Jul 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2026
Jul 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2026
Jul 28, 2026Board Meeting Intimation for Approval Of Un-Audit Financial Results For The Quarter Ended June 30 2026Jul 28, 2026
Jul 28, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 22, 2026
Jul 22, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 21, 2026
Jul 21, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotJul 20, 2026
Jul 20, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 17, 2026
Jul 17, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 09, 2026
Jul 09, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJul 09, 2026
Jul 09, 2026Board Meeting Outcome for Appointment Of Mr. Narasimha Raju As Chief Financial Officer Of The Company W.E.F. 09.07.2026Jul 09, 2026
Jul 09, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 01, 2026
Jul 01, 2026Closure of Trading WindowJun 30, 2026
Jun 30, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2026
Jun 09, 2026Appointment of Company Secretary and Compliance OfficerJun 02, 2026
Jun 02, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-CessationMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 13, 2026
May 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2026
May 12, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 11, 2026
May 11, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMay 11, 2026
May 11, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 07, 2026
May 07, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 07, 2026
May 07, 2026Announcement under Regulation 30 (LODR)-AcquisitionMay 07, 2026
May 07, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 07, 2026
May 07, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 07, 2026
May 07, 2026Corporate Action-Board approves DividendMay 07, 2026
May 07, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On May 07 2026May 07, 2026
May 07, 2026Audited Financial Results For The Quarter And Year Ended March 31 2026May 07, 2026
May 07, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 30, 2026
Apr 30, 2026Board Meeting Intimation for Board Meeting Intimation For To Consider And Approve The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2026.Apr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2026
Apr 10, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 09, 2026
Apr 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2026
Apr 02, 2026Closure of Trading WindowMar 28, 2026
Mar 28, 2026Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 16, 2026
Mar 16, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 71.04
ATR(14)
Volatile 56.84
STOCH(9,6)
Neutral 67.97
STOCH RSI(14)
Overbought 97.39
MACD(12,26)
Bullish 11.15
ADX(14)
Strong Trend 27.24
UO(9)
Bearish 56.45
ROC(12)
Uptrend And Accelerating 11.83
WillR(14)
Overbought -6.15
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across...more
Listing Date
14 Sept, 2021(4 Years, 10 Months, 30 Days)
Chairperson NameSura Surendranath Reddy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
